Sign in

Johns Hopkins Psychedelic Research Center

@jhpsychedelics.bsky.social
1K followers 28 following 263 posts

The Center for Psychedelic and Consciousness Research studies how psychedelics affect behavior, mood, cognition, brain function, & biological markers of health. linktr.ee/jhpsychedelics

PostsRepliesMedia
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 30/09/2026
We are seeking healthy individuals to take part in a Johns Hopkins research study. The study will look at the effects of psilocybin, a psychedelic drug, with pindolol (a medication that blocks a serotonin receptor).
100
Reposted by Johns Hopkins Psychedelic Research Center
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 02/09/2026
What should clinicians know about psychedelic-assisted treatments? Join our online CME/CE course for an evidence-based introduction to psychedelic medicine covering patient engagement, emerging research, and the future of psychedelic-assisted care. Register: hopkinscme.cloud-cme.com/course/cours...
023
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 24/09/2026
We are thrilled to share a major milestone for the Johns Hopkins Center for Psychedelic and Consciousness Research: Ceyda Sayalı, PhD, has received an R01 award from the National Institute on Alcohol Abuse and Alcoholism (NIAAA) — the first R01 awarded to an investigator at our Center.
191
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 23/09/2026
Dr. David Yaden @existwell.bsky.social was interviewed for the @rollingstone.com article on the rise of psychedelic spirituality in America, weighing in on what the research actually shows about belief change after psychedelic experiences. www.rollingstone.com/culture/cult...
rollingstone.com
Inside the New Psychedelic Awakening
Psychedelic have never been bigger. People are taking hallucinogens not for fun, but to find a deeper spiritual connection with the divine
051
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 22/09/2026
NPR covered the FDA hearing on psychedelics last week. CPCR postdoctoral fellow Dr. Eddie Jacobs spoke to the risks of adverse events occurring outside of a research setting.
110
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 21/09/2026
New paper – Validating and Creating a Short-Form of the Persisting Effects Questionnaire: A Measure of Positive and Negative Outcomes from Psychedelic Experiences
121
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 18/09/2026
Just 3 more weeks to sign up for our CME/CE course! The CPCR faculty led course will provide an evidence-based introduction to psychedelic medicine, covering patient engagement, emerging research, and the future of psychedelic-assisted care. Register at tinyurl.com/jhucme
001
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 17/09/2026
Representing Dr. David Yaden's (@existwell.bsky.social) lab at the CPCR & Hub at Oxford for Psychedelic Ethics (HOPE) — see Postdoc Eddie Jacobs, PhD from the FDA public hearing this week on the importance of safeguards based on standardized evidence on psychedelic treatments in clinical trials.
022
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 16/09/2026
Psychedelics are not risk-free. See our PSA video below. In recreational settings, risks can include panic, impaired judgment, worsening of psychiatric symptoms, and persistent perceptual changes, all of which can be compounded by unknown dosing.
131
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 16/09/2026
CPCR researchers at the Yaden Lab attended the FDA public hearing for the potential of psychedelics for therapeutic use.
121
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 14/09/2026
Join the Psychedelic Archives Project guest speaker series with Dr. Charles Nichols this Wednesday through the zoom link, no sign up is required. jhubluejays.zoom.us/j/92622903856
022
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 09/09/2026
Interested in experiencing psychedelics under professional supervision? We are seeking healthy adults ages 21-65 to participate in a clinical trial on the effects of psilocybin and its interaction with other medications. Apply at jhmi.co1.qualtrics.com/jfe/form/SV_....
010
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 04/09/2026
Dr. Charles Nichols joins us for the Psychedelic Archives Project guest speaker series, presenting “Psychedelic Use in Preconquest Mesoamerica: Probably Not What You’ve Been Told”, on Wednesday, September 16, 2026, at 4:30pm ET. Join on this Zoom link: jhubluejays.zoom.us/j/92622903856
172
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 02/09/2026
CPCR Associate Director, Dr. Albert Garcia-Romeu, alongside editors Dr. Scott Aaronson at Sheppard Pratt and Dr. Trisha Suppes at Stanford Medicine, recently published Psychedelics: Transforming Psychiatry.
100
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 02/09/2026
What should clinicians know about psychedelic-assisted treatments? Join our online CME/CE course for an evidence-based introduction to psychedelic medicine covering patient engagement, emerging research, and the future of psychedelic-assisted care. Register: hopkinscme.cloud-cme.com/course/cours...
023
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 01/09/2026
How comparable is psilocybin and Δ9-THC? Could the use of Δ9-THC help with the blinding problem we face in psychedelic trials? Check out our latest findings from @fredbarrettphd.bsky.social and colleagues.
021
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 01/09/2026
Johns Hopkins CPCR is hosting a satellite event for SfN 2026: Advancing Cross-Species Research in Psychedelic Neurosciences. Friday, November 13, 2026 · 9:00 a.m. – 7:00 p.m. Marriott Marquis Washington, DC Learn more at www.eventbrite.com/e/advancing-...
010
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 21/08/2026
This week, NPR featured novel data on the Oregon psilocybin services program. Associate Center Director, Dr. Albert Garcia-Romeu, weighed in on the newly published safety and mental health outcomes. See the digital story here: www.npr.org/2026/08/19/n...
npr.org
A real-world study of Oregon's nonmedical psilocybin program shows promise
Oregon was the first state to establish a legalized and regulated psilocybin industry. Since then, thousands have tried magic mushrooms. Here is the latest data from the state's real-life experiment.
062
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 12/08/2026
Dr. Azin Bekhrad, co-founder and psychiatrist at the Johns Hopkins Clinic for Post-Psychedelic Difficulties, spoke with Scientific American on the first year of the clinic: www.scientificamerican.com/article/firs...
scientificamerican.com
Psychedelic trips can go wrong—new clinics are there to help
As psychedelic therapies expand, new clinics treat uncommon long-term harms
043
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 06/08/2026
We are seeking healthy individuals to take part in a Johns Hopkins research study. The study will look at the effects of psilocybin, a psychedelic drug, with pindolol (a medication that blocks a serotonin receptor).
130
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 04/08/2026
What should psychedelic science take - and not take - from other disciplines? Join us in celebrating the book launch of The Oxford Handbook of Psychedelic, Religious, Spiritual, and Mystical Experiences on Wed, Aug 5th from 10am-2pm ET. Attend in-person in Washington DC or virtually on Zoom.
033
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 28/07/2026
Dr. David Yaden shares insights and safety considerations for Oregon’s psilocybin services program with the Oregon Capital Chronicle: oregoncapitalchronicle.com/2026/06/30/g...
oregoncapitalchronicle.com
Growing scope of Oregon psilocybin program raises safety concerns, study says • Oregon Capital Chronicle
Some of the top reasons people use Oregon's program include health and wellness, changes in perspective and "expanded concsiousness."
000
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 27/07/2026
Do you live with chronic low back pain and depression? You’re not alone. Our research team at Johns Hopkins is studying whether psilocybin may help with pain and mood. If you’d like to learn more or see if you qualify, visit the link below. hopkinspsychedelic.org/backpain
021
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 14/07/2026
Can Psychedelics Treat Addiction? Dr. Albert Garcia-Romeu was interviewed by Dr. Jonathan Avery on Thriving with Addiction podcast, discussing his research on the effects of psychedelics on addiction:
podcasts.apple.com
Can Psychedelics Treat Addiction? with Dr. Albert Garcia-Romeu
Podcast Episode · Thriving with Addiction with Dr. Jonathan Avery · July 14 · 40m · Video
010
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 07/07/2026
The CPCR is seeking a full-time Clinical Program Coordinator to join our team and support clinical trials and studies in the field of psychedelic science. Learn more and apply here: hiring.jhu.edu/careers/job/...
011
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 06/07/2026
Last month, CPCR Postdoctoral Research Fellow, David S. Rosen @docdurdur.bsky.social, presented neural and behavioral results from our music and psilocybin, non-drug, immersive listening pilot study at the Society for the Neuroscience of Creativity’s 2026 Conference in Philadelphia.
130
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 02/07/2026
We are seeking healthy individuals to take part in a Johns Hopkins research study. The study will look at the effects of psilocybin, a psychedelic drug, with pindolol (a medication that blocks a serotonin receptor).
252
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 02/07/2026
Congratulations to Dr. Praachi Tiwari on her promotion to faculty at the Johns Hopkins University School of Medicine!
131
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 01/07/2026
Congratulations to Dr. Gideon Naudé on his promotion to Research Associate in the School of Medicine!
110
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 26/06/2026
In a recent paper, CPCR researchers analyzed the first full year of data from the Oregon Health Authority, examining how Oregon’s policy has balanced safety and access to psychedelics outside of clinical settings. See the full paper here: www.sciencedirect.com/science/arti...
021
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 25/06/2026
Researchers at Johns Hopkins University are investigating psilocybin, a psychedelic substance found in some species of mushrooms, to see if it can help people with Amyotrophic Lateral Sclerosis (ALS) overcome depression.
140
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 24/06/2026
CPCR Associate Professor Dr. David Yaden was interviewed in an article with the Atlantic, providing insights on the safety, efficacy, and opportunities for psychedelic studies: www.theatlantic.com/health/2026/...
theatlantic.com
The New Science of Psychedelic Drugs
University researchers are looking for ways to engineer better mind-altering therapeutic experiences
032
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 18/06/2026
Join us Wednesday, June 24, 2026 at 4:30pm ET for the Psychedelic Archives Project guest speaker series, featuring Dr. Kurt Stocker, presenting “The Many Roads to Nonordinary Consciousness”. Join on this Zoom link: jhubluejays.zoom.us/j/92622903856
010
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 17/06/2026
Congratulations to Dr. Ceyda Sayalı on receiving the prestigious IBRO Rising Stars Award! 🧠 Her lab at Johns Hopkins combines brain stimulation, fMRI, and psychedelics like psilocybin to map how the brain rewires itself — work that could reshape treatment for depression and substance use disorders.
031
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 16/06/2026
The CPCR participated in Health Research Day 2026 at Canton Waterfront Park this past weekend. We had a great time connecting with community members! Thank you to Hopkins ICTR for organizing this event and bridging the gap between health research and the Baltimore community.
020
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 15/06/2026
CPCR Associate Director Dr. Albert Garcia-Romeu weighed in on a recent case report of psilocybin administration for an individual with suspected Alzheimer's Disease, noting some important concerns about the report. themicrodose.substack.com/p/an-amanita...
themicrodose.substack.com
An Amanita mushroom poisoning outbreak in California; A case report testing psilocybin for advanced Alzheimer’s disease
Plus: Scientists assess risk of psychedelic-induced mania; and the close of this season’s psychedelic legislation push
020
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 11/06/2026
Want to listen to music with psychedelics? Researchers at Johns Hopkins University are seeking healthy individuals ages 21-75 to participate in a research study evaluating the role of music during psychedelic experiences. Apply at jhmi.co1.qualtrics.com/jfe/form/SV_...
030
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 10/06/2026
Dr. Sandeep Nayak presented findings from our clinical trial of psilocybin for PTSD at the Interdisciplinary Conference on Psychedelic Research (ICPR) 2026 in the Netherlands. Stay tuned for full results published soon!
050
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 09/06/2026
Interested in experiencing psychedelics under professional supervision? We are seeking healthy adults between the ages 21-65 to participate in a new clinical trial looking at the effects of psilocybin and its interaction with other medications. Apply at jhmi.co1.qualtrics.com/jfe/form/SV_...
083
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 05/06/2026
CPCR Assistant Professor, Dr. Brandon Weiss, interviews with CNBC regarding the executive order on accelerated psychedelic research. Weiss cautions that there are different risks associated with each psychedelic compound:
100
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 03/06/2026
JHU PhD student Katherine Cheung and PhD Candidate Caleigh Propes, with CPCR Associate Professor Dr. David Yaden, evaluated comparison sets on the price of Oregon’s psilocybin services.
121
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 01/06/2026
Drs. Fred Barrett and David Yaden have received a 2026 Johns Hopkins Nexus Award alongside fellow JHU scientists, educators, bioethicists, and economists to advance critical conversations around the future of psychedelic policy. hub.jhu.edu/2026/05/29/j...
hub.jhu.edu
Johns Hopkins announces funding for Washington, D.C.-based projects and research
The Nexus Awards Program supports a diverse range of programming, research, and teaching activities at the Hopkins Bloomberg Center
032
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 26/05/2026
Join us tomorrow, Wednesday May 27, for the Psychedelic Archives Project Guest Speaker Series! 🎤Dr. Timo Schmidt ( @Titoschmi ) 🗓 May 25, 2026 | ⏰ 4:30 PM EDT 🎟 Free to attend — sign up at the link below and in our bio!👇 jhubluejays.zoom.us/j/92622903856
021
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 26/05/2026
Congratulations to Kristy Arthur on an outstanding showing at the Collaborative Perspectives on Addiction Annual Meeting!
110
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 25/05/2026
This Memorial Day, we honor those who gave everything in service to this country and we hold space for those still carrying invisible wounds.
100
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 22/05/2026
Check out this thoughtful interview with Dr. Bit Yaden and Josh Hardman at Psychedelic Alpha, discussing a collaborative educational project between Johns Hopkins, NYU, Penn, and Yale. psychedelicalpha.com/news/bit-yad...
psychedelicalpha.com
Bit Yaden on Preparing the Next Generation of Psychiatrists for a Psychedelic Future
We speak to Dr. Bit Yaden about a multi-instituion project to teach psychedelic medicine to resident psychiatrists.
021
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 21/05/2026
CPCR Medical Director, Dr. Sandeep Nayak, interviews with Forbes on the psychedelic compound, methylone, being explored in FDA-approved research for post-traumatic stress disorder: www.forbes.com/health/mind/...
forbes.com
What Is Methylone? One Psychedelic Drug Getting FDA Fast-Track Status
020
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 20/05/2026
CPCR Medical Director, Dr. Sandeep Nayak, will be speaking at the Interdisciplinary Conference on Psychedelic Research in the Netherlands on June 4-6!
041
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 19/05/2026
Rodrigo Guerra, biomedical engineering PhD candidate with the CPCR, was recognized as 2026 Graduate Student Employee of the Year in April! This award is reserved for those who go above and beyond in their roles among thousands of undergrad and graduate student employees at Johns Hopkins University.
140
Johns Hopkins Psychedelic Research Center @jhpsychedelics.bsky.social · 15/05/2026
We are seeking individuals to participate in a research study on the effects of psychedelics on addictive behaviors including problems with gambling, video gaming, internet/social media, pornography and other sexual behaviors, and shopping and buying behaviors. hopkinspsychedelic.org/addictionsur...
010